Home › Autoimmune Diseases › Tennessee
Autoimmune Diseases clinical trials in Tennessee
10 studies for Autoimmune Diseases are looking for participants at sites in Tennessee.
Cities in Tennessee
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Vanderbilt University Medical Center - Accepting Adult Patients, Nashville
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252Abatacept for the Treatment of Giant Cell Arteritis
- Vanderbilt University, Nashville
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Knoxville Kidney Center Pllc, Brentwood
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- St. Jude Childrens; Research Hospital, Memphis
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 6, 2026 · NCT06056297Study of BHV-1300 in Graves' Disease
- Site-107, Memphis
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1021, Memphis
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Regional One Health, Memphis
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
- Toyos Clinic, Nashville
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 85 · All sexes · Updated May 11, 2025 · NCT06964269From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.